Huntington National Bank / ABT
Huntington National Bank’s Abbott Laboratories Position
Does Huntington National Bank own Abbott Laboratories (ABT)? Yes — 404.9K shares worth $42M (+0.23% of its 13F portfolio) as of Q1 2026, up from 390.8K shares the prior filed quarter.
Position Value
$42M
Q1 2026
Shares
404.9K
% of Portfolio
+0.23%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 404.9K | $42M | +0.23% |
| Q4 2025 | 390.8K | $49M | +0.29% |
| Q3 2025 | 399.5K | $54M | +0.33% |
| Q2 2025 | 402.6K | $55M | +0.36% |
| Q1 2025 | 405.7K | $54M | +0.39% |
| Q4 2024 | 444.3K | $50M | +0.36% |
| Q3 2024 | 436.1K | $50M | +0.36% |
| Q2 2024 | 444.3K | $46M | +0.36% |
| Q1 2024 | 461.9K | $52M | +0.42% |
| Q4 2023 | 469.4K | $52M | +0.47% |
| Q3 2023 | 528.3K | $51M | +0.51% |
| Q2 2023 | 536.1K | $58M | +0.54% |
| Q1 2023 | 538.7K | $55M | +0.54% |
| Q4 2022 | 551.6K | $61M | +0.63% |
| Q3 2022 | 561.9K | $54M | +0.62% |
| Q2 2022 | 578.2K | $63M | +0.68% |
| Q1 2022 | 581.5K | $69M | +0.64% |
| Q4 2021 | 583.7K | $82M | +0.75% |
| Q3 2021 | 586.6K | $69M | +0.69% |
| Q2 2021 | 579.9K | $67M | +0.67% |
| Q1 2021 | 500.4K | $60M | +0.72% |
| Q4 2020 | 512.0K | $56M | +0.73% |
| Q3 2020 | 517.9K | $56M | +0.82% |
| Q2 2020 | 528.9K | $48M | +0.76% |
| Q1 2020 | 531.7K | $42M | +0.79% |
| Q4 2019 | 541.7K | $47M | +0.71% |
| Q3 2019 | 571.2K | $48M | +0.77% |
| Q2 2019 | 541.1K | $46M | +0.73% |
| Q1 2019 | 574.0K | $46M | +0.76% |
| Q4 2018 | 603.8K | $44M | +0.78% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Huntington National Bank’s full portfolio or all institutional holders of ABT.